Skip Navigation

Cardiovascular Research 2003 57(2):395-404; doi:10.1016/S0008-6363(02)00663-6
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Du, X.-J.
Right arrow Articles by Tregear, G. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du, X.-J.
Right arrow Articles by Tregear, G. W
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype

Xiao-Jun Dua,*, Chrishan S Samuelb, Xiao-Ming Gaoa, Ling Zhaob,1, Laura J Parryb and Geoffrey W Tregearb

aExperimental Cardiology Laboratory, Baker Medical Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, Vic. 8008, Australia
bHoward Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Melbourne, Vic. 3010, Australia

* Corresponding author. Tel.: +61-3-8530-1294; fax: +61-3-8530-1100. xiaojun.du{at}baker.edu.au

Objective: To investigate cardiac phenotypes in mice deficient in the peptide hormone relaxin by gene targeting. Methods: Echocardiography and cardiac catheterization were performed on male and female relaxin deficient (Rlx–/–) mice as well as heterozygous (Rlx+/–) and wildtype (Rlx+/+) littermates aged between 8 and 24 months. Collagen expression and content in the heart were analysed by real-time PCR, hydroxyproline assay and histology. Results: Heart rate, blood pressures, left ventricular (LV) dimensions, fractional shortening and maximal and minimal dP/dt did not differ significantly between the three genotypes of either gender at any age. However, 8–10-month-old Rlx–/– males exhibited a greater transmitral flow velocity (A-wave) at the late LV diastolic phase. Male Rlx–/– mice aged between 12 and 24 months had significantly higher LV end-diastolic pressures, a 30% increase in atrial weight and 10–30% increases in lung and liver weights. Male mice also showed an age-dependent increase (P<0.01) in LV collagen content that was more pronounced in Rlx–/– than control littermates (P<0.01). Procollagen type-1 expression was also significantly higher in the LV of Rlx–/– males compared with either Rlx+/– or Rlx+/+ males at 6, 9 and 12 months of age. Age-matched female Rlx–/– mice did not display any of these cardiac phenotypes seen in Rlx–/– males. Conclusions: Male Rlx–/– mice had impeded LV diastolic filling and increased atrial weights, most likely due to an increase in ventricular collagen content and chamber stiffness. These phenotypes in the Rlx–/– males were not observed in Rlx–/– females, indicating the importance of other gender-related factors in cardiovascular function.

KEYWORDS Fibrosis; Gender; Gene expression; Hormones; Ventricular function


1 Present address: Laboratory of Genetics and Physiology, NIDDK, NIH, Bethesda, MD 20892, USA.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
HypertensionHome page
N. N. Huynh, K. L. Andrews, G. A. Head, S. M.L. Khong, D. N. Mayorov, A. J. Murphy, G. Lambert, H. Kiriazis, Q. Xu, X.-J. Du, et al.
Arginase II Knockout Mouse Displays a Hypertensive Phenotype Despite a Decreased Vasoconstrictory Profile
Hypertension, August 1, 2009; 54(2): 294 - 301.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
G. E. Haddad, L. J. Saunders, S. D. Crosby, M. Carles, F. del Monte, K. King, M. R. Bristow, F. G. Spinale, T. E. Macgillivray, M. J. Semigran, et al.
Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences
Physiol Genomics, April 1, 2008; 33(2): 267 - 277.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q. Xu, E. D. Lekgabe, X.-M. Gao, Z. Ming, G. W. Tregear, A. M. Dart, R. A. D. Bathgate, C. S. Samuel, and X.-J. Du
Endogenous Relaxin Does Not Affect Chronic Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
Endocrinology, February 1, 2008; 149(2): 476 - 482.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. P. Konhilas and L. A. Leinwand
The Effects of Biological Sex and Diet on the Development of Heart Failure
Circulation, December 4, 2007; 116(23): 2747 - 2759.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
R. Wachter, C. Luers, S. Kleta, K. Griebel, C. Herrmann-Lingen, L. Binder, N. Janicke, D. Wetzel, M. M. Kochen, and B. Pieske
Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension
Eur J Heart Fail, May 1, 2007; 9(5): 469 - 476.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X.-l. Moore, S.-l. Tan, C.-y. Lo, L. Fang, Y.-D. Su, X.-M. Gao, E. A. Woodcock, R. J. Summers, G. W. Tregear, R. A. D. Bathgate, et al.
Relaxin Antagonizes Hypertrophy and Apoptosis in Neonatal Rat Cardiomyocytes
Endocrinology, April 1, 2007; 148(4): 1582 - 1589.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. D. Hewitson, I. Mookerjee, R. Masterson, C. Zhao, G. W. Tregear, G. J. Becker, and C. S. Samuel
Endogenous Relaxin Is a Naturally Occurring Modulator of Experimental Renal Tubulointerstitial Fibrosis
Endocrinology, February 1, 2007; 148(2): 660 - 669.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. D. Lekgabe, S. G. Royce, T. D. Hewitson, M. L. K. Tang, C. Zhao, X. L. Moore, G. W. Tregear, R. A. D. Bathgate, X.-J. Du, and C. S. Samuel
The Effects of Relaxin and Estrogen Deficiency on Collagen Deposition and Hypertrophy of Nonreproductive Organs
Endocrinology, December 1, 2006; 147(12): 5575 - 5583.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-J. Du, X.-M. Gao, H. Kiriazis, X.-L. Moore, Z. Ming, Y. Su, A. M. Finch, R. A. Hannan, A. M. Dart, and R. M. Graham
Transgenic {alpha}1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival
Cardiovasc Res, September 1, 2006; 71(4): 735 - 743.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers
International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides.
Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Mookerjee, N. R. Solly, S. G. Royce, G. W. Tregear, C. S. Samuel, and M. L. K. Tang
Endogenous Relaxin Regulates Collagen Deposition in an Animal Model of Allergic Airway Disease
Endocrinology, February 1, 2006; 147(2): 754 - 761.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Feng, N. V. Bogatcheva, A. A. Kamat, A. Truong, and A. I. Agoulnik
Endocrine Effects of Relaxin Overexpression in Mice
Endocrinology, January 1, 2006; 147(1): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
C. S. Samuel
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Clin. Med. Res., November 1, 2005; 3(4): 241 - 249.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. D. Lekgabe, H. Kiriazis, C. Zhao, Q. Xu, X. L. Moore, Y. Su, R. A.D. Bathgate, X.-J. Du, and C. S. Samuel
Relaxin Reverses Cardiac and Renal Fibrosis in Spontaneously Hypertensive Rats
Hypertension, August 1, 2005; 46(2): 412 - 418.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
L. Wakefield, V. Cornish, F. Broackes-Carter, and E. Sim
Arylamine N-acetyltransferase 2 Expression in the Developing Heart
J. Histochem. Cytochem., May 1, 2005; 53(5): 583 - 592.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. A. Kamat, S. Feng, N. V. Bogatcheva, A. Truong, C. E. Bishop, and A. I. Agoulnik
Genetic Targeting of Relaxin and Insulin-Like Factor 3 Receptors in Mice
Endocrinology, October 1, 2004; 145(10): 4712 - 4720.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. S. Samuel, E. N. Unemori, I. Mookerjee, R. A. D. Bathgate, S. L. Layfield, J. Mak, G. W. Tregear, and X.-J. Du
Relaxin Modulates Cardiac Fibroblast Proliferation, Differentiation, and Collagen Production and Reverses Cardiac Fibrosis in Vivo
Endocrinology, September 1, 2004; 145(9): 4125 - 4133.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
X.-J. Du
Gender modulates cardiac phenotype development in genetically modified mice
Cardiovasc Res, August 15, 2004; 63(3): 510 - 519.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. P. Conrad and J. Novak
Emerging role of relaxin in renal and cardiovascular function
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Hocher, R. Ziebig, R. Krause, G. Asmus, H.-H Neumayer, L. Liefeldt, and J.-P. Stasch
Relaxin Is an Independent Risk Factor Predicting Death in Male Patients With End-Stage Kidney Disease
Circulation, May 18, 2004; 109(19): 2266 - 2268.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
O. D. Sherwood
Relaxin's Physiological Roles and Other Diverse Actions
Endocr. Rev., April 1, 2004; 25(2): 205 - 234.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. A. M. Krajnc-Franken, A. J. M. van Disseldorp, J. E. Koenders, S. Mosselman, M. van Duin, and J. A. Gossen
Impaired Nipple Development and Parturition in LGR7 Knockout Mice
Mol. Cell. Biol., January 15, 2004; 24(2): 687 - 696.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.